Cargando…

N-glycosylation of somatostatin receptor type 2 protects rats from acute pancreatitis

BACKGROUND: The growth hormone inhibitor somatostatin and its analogs are promising therapeutic agents for acute pancreatitis. However, the therapeutic effects remain controversial. Somatostatin analogs preferentially bind to somatostatin receptor 2 (SSTR2), and this study aimed to investigate wheth...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Ming, Chen, Min-Min, Han, Dong, Chen, Wei, Xu, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667150/
https://www.ncbi.nlm.nih.gov/pubmed/34988176
http://dx.doi.org/10.21037/atm-21-5249
_version_ 1784614342254133248
author Huang, Ming
Chen, Min-Min
Han, Dong
Chen, Wei
Xu, Feng
author_facet Huang, Ming
Chen, Min-Min
Han, Dong
Chen, Wei
Xu, Feng
author_sort Huang, Ming
collection PubMed
description BACKGROUND: The growth hormone inhibitor somatostatin and its analogs are promising therapeutic agents for acute pancreatitis. However, the therapeutic effects remain controversial. Somatostatin analogs preferentially bind to somatostatin receptor 2 (SSTR2), and this study aimed to investigate whether N-glycosylation affects SSTR2 stability, membrane trafficking, and signal transduction. METHODS: Western blot analysis following PNGase F digestion was performed to confirm N-glycosylation of SSTR2 in rat pancreatic acinar AR42J cells. Rats were subjected to 4 hourly intraperitoneal injections of cerulein (50 µg/kg) plus LPS (5 µg/mL) to induce acute pancreatitis. Mass spectrometry was conducted to identify the glycosylation sites of SSTR2, and immunofluorescent staining was carried out to examine the localization of wild-type and asparagine 9 (N9)Q-mutant SSTR2. Proteasome inhibitor MG132 was employed to assess the stability of SSTR2, and overexpression of wild-type or N9Q-mutant SSTR2 was used to examine the role of N-glycosylation in SSTR2 signal transduction in vitro and its therapeutic effect on pancreatitis in rats. RESULTS: SSTR2 protein in AR42J cells was N-glycosylated at the N9 residue. Wild-type SSTR2 localized in the plasma membrane whereas N9Q-mutant SSTR2 was retained in the endoplasmic reticulum (ER). MG132 rapidly restored the ectopic expression of mutant but not wild-type SSTR2 protein in AR42J cells. Overexpression of wild-type but not N9Q-mutant SSTR2 activated NF-κB signaling and facilitated nuclear transportation of p65 in AR42J cells upon cerulein plus LPS stimulation. Furthermore, pretreatment with wild-type but not N9Q-mutant SSTR2-overexpressing vectors significantly ameliorated biochemical parameters and pancreatic histological impairments in rats with pancreatitis. CONCLUSIONS: N-glycosylation of SSTR2 is essential for membrane localization, stability, and signal transduction of SSTR2 in pancreatic cells, playing a protective role in experimental acute pancreatitis.
format Online
Article
Text
id pubmed-8667150
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-86671502022-01-04 N-glycosylation of somatostatin receptor type 2 protects rats from acute pancreatitis Huang, Ming Chen, Min-Min Han, Dong Chen, Wei Xu, Feng Ann Transl Med Original Article BACKGROUND: The growth hormone inhibitor somatostatin and its analogs are promising therapeutic agents for acute pancreatitis. However, the therapeutic effects remain controversial. Somatostatin analogs preferentially bind to somatostatin receptor 2 (SSTR2), and this study aimed to investigate whether N-glycosylation affects SSTR2 stability, membrane trafficking, and signal transduction. METHODS: Western blot analysis following PNGase F digestion was performed to confirm N-glycosylation of SSTR2 in rat pancreatic acinar AR42J cells. Rats were subjected to 4 hourly intraperitoneal injections of cerulein (50 µg/kg) plus LPS (5 µg/mL) to induce acute pancreatitis. Mass spectrometry was conducted to identify the glycosylation sites of SSTR2, and immunofluorescent staining was carried out to examine the localization of wild-type and asparagine 9 (N9)Q-mutant SSTR2. Proteasome inhibitor MG132 was employed to assess the stability of SSTR2, and overexpression of wild-type or N9Q-mutant SSTR2 was used to examine the role of N-glycosylation in SSTR2 signal transduction in vitro and its therapeutic effect on pancreatitis in rats. RESULTS: SSTR2 protein in AR42J cells was N-glycosylated at the N9 residue. Wild-type SSTR2 localized in the plasma membrane whereas N9Q-mutant SSTR2 was retained in the endoplasmic reticulum (ER). MG132 rapidly restored the ectopic expression of mutant but not wild-type SSTR2 protein in AR42J cells. Overexpression of wild-type but not N9Q-mutant SSTR2 activated NF-κB signaling and facilitated nuclear transportation of p65 in AR42J cells upon cerulein plus LPS stimulation. Furthermore, pretreatment with wild-type but not N9Q-mutant SSTR2-overexpressing vectors significantly ameliorated biochemical parameters and pancreatic histological impairments in rats with pancreatitis. CONCLUSIONS: N-glycosylation of SSTR2 is essential for membrane localization, stability, and signal transduction of SSTR2 in pancreatic cells, playing a protective role in experimental acute pancreatitis. AME Publishing Company 2021-11 /pmc/articles/PMC8667150/ /pubmed/34988176 http://dx.doi.org/10.21037/atm-21-5249 Text en 2021 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Huang, Ming
Chen, Min-Min
Han, Dong
Chen, Wei
Xu, Feng
N-glycosylation of somatostatin receptor type 2 protects rats from acute pancreatitis
title N-glycosylation of somatostatin receptor type 2 protects rats from acute pancreatitis
title_full N-glycosylation of somatostatin receptor type 2 protects rats from acute pancreatitis
title_fullStr N-glycosylation of somatostatin receptor type 2 protects rats from acute pancreatitis
title_full_unstemmed N-glycosylation of somatostatin receptor type 2 protects rats from acute pancreatitis
title_short N-glycosylation of somatostatin receptor type 2 protects rats from acute pancreatitis
title_sort n-glycosylation of somatostatin receptor type 2 protects rats from acute pancreatitis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667150/
https://www.ncbi.nlm.nih.gov/pubmed/34988176
http://dx.doi.org/10.21037/atm-21-5249
work_keys_str_mv AT huangming nglycosylationofsomatostatinreceptortype2protectsratsfromacutepancreatitis
AT chenminmin nglycosylationofsomatostatinreceptortype2protectsratsfromacutepancreatitis
AT handong nglycosylationofsomatostatinreceptortype2protectsratsfromacutepancreatitis
AT chenwei nglycosylationofsomatostatinreceptortype2protectsratsfromacutepancreatitis
AT xufeng nglycosylationofsomatostatinreceptortype2protectsratsfromacutepancreatitis